{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:15:33Z","timestamp":1775978133479,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p><jats:italic>CDKN1B<\/jats:italic> mutations were established as a cause of multiple endocrine neoplasia 4 (MEN4) syndrome in patients with MEN1 phenotype without a mutation in the <jats:italic>MEN1<\/jats:italic> gene. In addition, variants in other cyclin-dependent kinase inhibitors (<jats:italic>CDKIs<\/jats:italic>) were found in some MEN1-like cases without the <jats:italic>MEN1<\/jats:italic> mutation. We aimed to describe novel germline mutations of these genes in patients with primary hyperparathyroidism (PHPT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>During genetic screening for familial hyperparathyroidism, three novel <jats:italic>CDKIs<\/jats:italic> germline mutations in three unrelated cases between January 2019 and November 2021 were identified. In this report, we describe clinical features, DNA sequence analysis, and familial segregation studies based on these patients and their relatives. Genome-wide DNA study of loss of heterozygosity (LOH), copy number variation (CNV), and p27\/kip immunohistochemistry was performed on tumour samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>DNA screening was performed for atypical parathyroid adenomas in cases 1 and 2 and for cystic parathyroid adenoma and young age at diagnosis of PHPT in case 3. Genetic analysis identified likely pathogenic variants of <jats:italic>CDKN1B<\/jats:italic> in cases 1 and 2 and a variant of the uncertain significance of <jats:italic>CDKN2C<\/jats:italic>, with uniparental disomy in the tumour sample, in case 3. Neoplasm screening of probands showed other non-endocrine tumours in case 1 (colon adenoma with dysplasia and atypical lipomas) and case 2 (aberrant T-cell population) and a non-functional pituitary adenoma in case 3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Germline mutations in <jats:italic>CDKIs<\/jats:italic> should be included in gene panels for genetic testing of primary hyperparathyroidism. New germline variants here described can be added to the current knowledge.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-022-01948-7","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T07:04:51Z","timestamp":1667631891000},"page":"829-840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-7650","authenticated-orcid":false,"given":"I.","family":"Mazarico-Altisent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Capel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Baena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Bella-Cueto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Barcons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Guirao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Caix\u00e0s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rigla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,5]]},"reference":[{"key":"1948_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joim.12523","volume":"280","author":"RV Thakker","year":"2016","unstructured":"Thakker RV (2016) Genetics of parathyroid tumours. J Intern Med 280:574\u2013583","journal-title":"J Intern Med"},{"key":"1948_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","volume":"89","author":"D Trump","year":"1996","unstructured":"Trump D, Farren B, Wooding C et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89:653\u2013669. https:\/\/doi.org\/10.1093\/qjmed\/89.9.653","journal-title":"Q J Med"},{"key":"1948_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","volume":"24","author":"RV Thakker","year":"2010","unstructured":"Thakker RV (2010) Multiple endocrine neoplasia type 1 (MEN1). Best Pract Res Clin Endocrinol Metab 24:355\u2013370","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"1948_CR4","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A et al (2001) CONSENSUS guidelines for diagnosis and therapy of MEN type 1 and type 2. JCEM 86(12):5658\u20135671. https:\/\/doi.org\/10.1210\/jcem.86.12.8070","journal-title":"JCEM"},{"key":"1948_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22\u201332. https:\/\/doi.org\/10.1002\/humu.20605","journal-title":"Hum Mutat"},{"key":"1948_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc1610","volume":"5","author":"SJ Marx","year":"2005","unstructured":"Marx SJ (2005) Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer 5:367\u2013375. https:\/\/doi.org\/10.1038\/nrc1610","journal-title":"Nat Rev Cancer"},{"key":"1948_CR7","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1507\/endocrj.46.811","volume":"46","author":"H Namihira","year":"1999","unstructured":"Namihira H, Sato M, Matsubara S et al (1999) Mutation MEND gene in a case of familial neoplasia type of germline or somatic multiple. Endocr J 46:811\u2013816","journal-title":"Endocr J"},{"key":"1948_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.6061\/clinics\/2012(Sup01)04","volume":"67","author":"NS Pellegata","year":"2012","unstructured":"Pellegata NS (2012) MENX and MEN4. Clinics 67:13\u201318. https:\/\/doi.org\/10.6061\/clinics\/2012(Sup01)04","journal-title":"Clinics"},{"key":"1948_CR10","doi-asserted-by":"publisher","first-page":"R235","DOI":"10.1530\/EJE-19-0602","volume":"181","author":"S Vandeva","year":"2019","unstructured":"Vandeva S, Daly AF, Petrossians P et al (2019) Somatic and germline mutations in the pathogenesis of pituitary adenomas. Eur J Endocrinol 181:R235\u2013R254. https:\/\/doi.org\/10.1530\/EJE-19-0602","journal-title":"Eur J Endocrinol"},{"key":"1948_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"Thakker RV (2014) Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386:2\u201315","journal-title":"Mol Cell Endocrinol"},{"key":"1948_CR12","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"P Natalia","year":"2006","unstructured":"Natalia P, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, H\u00f6fler H, Fend F, Jochen Graw MJA (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci 103:15558\u201315563. https:\/\/doi.org\/10.1073\/pnas.0603877103","journal-title":"Proc Natl Acad Sci"},{"key":"1948_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1365-2265.2002.01505.x","volume":"56","author":"BM Cavaco","year":"2002","unstructured":"Cavaco BM, Domingues R, Bacelar MC et al (2002) Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clin Endocrinol (Oxf) 56:465\u2013473. https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01505.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1948_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2265.2007.03045.x","volume":"68","author":"M Owens","year":"2008","unstructured":"Owens M, Ellard S, Vaidya B (2008) Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 68:350\u2013354. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03045.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1948_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000345670","volume":"41","author":"M Lee","year":"2013","unstructured":"Lee M, Pellegata NS (2013) Multiple endocrine neoplasia type 4. Front Horm Res 41:63\u201378. https:\/\/doi.org\/10.1159\/000345670","journal-title":"Front Horm Res"},{"key":"1948_CR16","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1210\/jc.2008-2083","volume":"94","author":"SK Agarwal","year":"2009","unstructured":"Agarwal SK, Mateo CM, Marx SJ (2009) Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 94:1826\u20131834. https:\/\/doi.org\/10.1210\/jc.2008-2083","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000371819","volume":"103","author":"MH Schernthaner-Reiter","year":"2016","unstructured":"Schernthaner-Reiter MH, Trivellin G, Stratakis CA (2016) MEN1, MEN4, and carney complex: pathology and molecular genetics. Neuroendocrinology 103:18\u201331. https:\/\/doi.org\/10.1159\/000371819","journal-title":"Neuroendocrinology"},{"key":"1948_CR18","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1210\/jc.2006-2563","volume":"92","author":"A Ozawa","year":"2007","unstructured":"Ozawa A, Agarwal SK, Mateo CM et al (2007) The parathyroid\/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. J Clin Endocrinol Metab 92:1948\u20131951. https:\/\/doi.org\/10.1210\/jc.2006-2563","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2265.2008.03379.x","volume":"70","author":"S Igreja","year":"2009","unstructured":"Igreja S, Chahal HS, Akker SA et al (2009) Blackwell Publishing Ltd assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations. Clin Endocrinol 70:259\u2013264. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03379.x","journal-title":"Clin Endocrinol"},{"key":"1948_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003350","author":"G Occhi","year":"2013","unstructured":"Occhi G, Regazzo D, Trivellin G et al (2013) A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype. PLoS Genet. https:\/\/doi.org\/10.1371\/journal.pgen.1003350","journal-title":"PLoS Genet"},{"key":"1948_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.beem.2018.09.011","volume":"32","author":"F Alberto","year":"2018","unstructured":"Alberto F (2018) Genetics of parathyroids disorders: overview. Best Pract Res Clin Endocrinol Metab 32:781\u2013790","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1948_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","volume":"3","author":"LF Starker","year":"2012","unstructured":"Starker LF, \u00c5kerstr\u00f6m T, Long WD et al (2012) Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer 3:44\u201351. https:\/\/doi.org\/10.1007\/s12672-011-0100-8","journal-title":"Horm Cancer"},{"key":"1948_CR23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1126\/science.1126100","volume":"312","author":"O Vierimaa","year":"2006","unstructured":"Vierimaa O, Georgitsi M, Lehtonen R et al (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science (80-) 312:1228\u20131230. https:\/\/doi.org\/10.1126\/science.1126100","journal-title":"Science (80-)"},{"issue":"OC1","key":"1948_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/endoabs.63.OC1.1","volume":"63","author":"S Mariathasan","year":"2019","unstructured":"Mariathasan S, Andrews K, Thompson E et al (2019) Genetic testing for hereditary hyperparathyroidism in a large UK cohort. Endocr Abstr 63(OC1):1. https:\/\/doi.org\/10.1530\/endoabs.63.OC1.1","journal-title":"Endocr Abstr"},{"key":"1948_CR25","doi-asserted-by":"publisher","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C et al (2013) From fastQ data to high-confidence variant calls: the genome analysis toolkit best practices pipeline. Curr Protoc Bioinform 43:11.10.1-11.10.33. https:\/\/doi.org\/10.1002\/0471250953.bi1110s43","journal-title":"Curr Protoc Bioinform"},{"key":"1948_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"1948_CR27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/imj.14394","volume":"49","author":"JE McDonnell","year":"2019","unstructured":"McDonnell JE, Gild ML, Clifton-Bligh RJ, Robinson BG (2019) Multiple endocrine neoplasia: an update. Intern Med J 49:954\u2013961. https:\/\/doi.org\/10.1111\/imj.14394","journal-title":"Intern Med J"},{"key":"1948_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11102-018-0885-3","volume":"21","author":"V Klyn","year":"2018","unstructured":"Klyn V, Dekeyzer S, Van Eetvelde R et al (2018) Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3T MRI and between 2D\u2013T1 spin-echo- and 3D\u2013T1 gradient-echo sequences. Pituitary 21:379\u2013383. https:\/\/doi.org\/10.1007\/s11102-018-0885-3","journal-title":"Pituitary"},{"key":"1948_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.leukres.2004.06.007","volume":"29","author":"V Pappa","year":"2005","unstructured":"Pappa V, Papageorgiou S, Papageorgiou E et al (2005) A novel p27 gene mutation in a case of unclassified myeloproliferative disorder. Leuk Res 29:229\u2013231. https:\/\/doi.org\/10.1016\/j.leukres.2004.06.007","journal-title":"Leuk Res"},{"key":"1948_CR30","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/sj\/leu\/2402408","volume":"16","author":"C Takeuchi","year":"2002","unstructured":"Takeuchi C, Takeuchi S, Ikezoe T et al (2002) Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate. Leukemia 16:956\u2013958. https:\/\/doi.org\/10.1038\/sj\/leu\/2402408","journal-title":"Leukemia"},{"key":"1948_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/apt.13324","volume":"42","author":"L Lundell","year":"2015","unstructured":"Lundell L, Vieth M, Gibson F et al (2015) Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther 42:649\u2013663. https:\/\/doi.org\/10.1111\/apt.13324","journal-title":"Aliment Pharmacol Ther"},{"key":"1948_CR32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.arcmed.2013.10.009","volume":"44","author":"CL Meuwese","year":"2013","unstructured":"Meuwese CL, Carrero JJ (2013) Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg? Arch Med Res 44:591\u2013600. https:\/\/doi.org\/10.1016\/j.arcmed.2013.10.009","journal-title":"Arch Med Res"},{"key":"1948_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12672-013-0147-9","volume":"4","author":"J Costa-Guda","year":"2013","unstructured":"Costa-Guda J, Soong CP, Parekh VI et al (2013) Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas. Horm Cancer 4:301\u2013307. https:\/\/doi.org\/10.1007\/s12672-013-0147-9","journal-title":"Horm Cancer"},{"key":"1948_CR34","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1359\/jbmr.1997.12.9.1330","volume":"12","author":"H Tahara","year":"1997","unstructured":"Tahara H, Smith AP, Gaz RD et al (1997) Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate. J Bone Miner Res 12:1330\u20131334. https:\/\/doi.org\/10.1359\/jbmr.1997.12.9.1330","journal-title":"J Bone Miner Res"},{"key":"1948_CR35","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.32388\/zhve0o","volume":"81","author":"H Tahara","year":"1996","unstructured":"Tahara H (1996) Loss of chromosome arm 9p DNA and analysis of the ~16 and ~15 Cyclin-dependent kinase inhibitor genes in human parathyroid adenomas*. JCEM 81:3663\u20133667. https:\/\/doi.org\/10.32388\/zhve0o","journal-title":"JCEM"},{"key":"1948_CR36","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1210\/jc.2006-2843","volume":"92","author":"M Georgitsi","year":"2007","unstructured":"Georgitsi M, Raitila A, Karhu A et al (2007) Brief report: germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92:3321\u20133325. https:\/\/doi.org\/10.1210\/jc.2006-2843","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR37","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1365-2265.2011.04269.x","volume":"76","author":"O Belar","year":"2012","unstructured":"Belar O, De La Hoz C, P\u00e9rez-Nanclares G et al (2012) Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain. Clin Endocrinol (Oxf) 76:719\u2013724. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04269.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1948_CR38","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/humu.21354","volume":"31","author":"S Molatore","year":"2010","unstructured":"Molatore S, Marinoni I, Lee M et al (2010) A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Hum Mutat 31:1825\u20131835. https:\/\/doi.org\/10.1002\/humu.21354","journal-title":"Hum Mutat"},{"key":"1948_CR39","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0080","author":"F Tonelli","year":"2014","unstructured":"Tonelli F, Giudici F, Giusti F et al (2014) A heterozygous frameshift mutation in exon 1 of cdkn1B gene in a patient affected by MEN4 syndrome. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-14-0080","journal-title":"Eur J Endocrinol"},{"key":"1948_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EC-14-0116","volume":"4","author":"E Pardi","year":"2015","unstructured":"Pardi E, Mariotti S, Pellegata NS et al (2015) Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4. Endocr Connect 4:1\u20138. https:\/\/doi.org\/10.1530\/EC-14-0116","journal-title":"Endocr Connect"},{"key":"1948_CR41","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1210\/clinem\/dgac162","volume":"107","author":"A Seabrook","year":"2022","unstructured":"Seabrook A, Wijewardene A, de Sousa S et al (2022) MEN4, the MEN1 mimicker; a case series of 3 phenotypically heterogenous patients with unique CDKN1B mutations. J Clin Endocrinol Metab 107:2339\u20132349. https:\/\/doi.org\/10.1210\/clinem\/dgac162","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR42","doi-asserted-by":"publisher","first-page":"E701","DOI":"10.1210\/jc.2010-1338","volume":"96","author":"J Costa-Guda","year":"2011","unstructured":"Costa-Guda J, Marinoni I, Molatore S et al (2011) Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas. J Clin Endocrinol Metab 96:E701\u2013E706. https:\/\/doi.org\/10.1210\/jc.2010-1338","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-213934","author":"MJ Bugalho","year":"2016","unstructured":"Bugalho MJ, Domingues R (2016) Uncommon association of cerebral meningioma, parathyroid adenoma and papillary thyroid carcinoma in a patient harbouring a rare germline variant in the CDKN1B gene. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2015-213934","journal-title":"BMJ Case Rep"},{"key":"1948_CR44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12020-016-0941-6","volume":"55","author":"S Borsari","year":"2017","unstructured":"Borsari S, Pardi E, Pellegata NS et al (2017) Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas. Endocrine 55:386\u2013397. https:\/\/doi.org\/10.1007\/s12020-016-0941-6","journal-title":"Endocrine"},{"key":"1948_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-015-0540-y","volume":"49","author":"S Sambugaro","year":"2015","unstructured":"Sambugaro S, Di Ruvo M, Ambrosio MR et al (2015) Early onset acromegaly associated with a novel deletion in CDKN1B 5\u2032UTR region. Endocrine 49:58\u201364. https:\/\/doi.org\/10.1007\/s12020-015-0540-y","journal-title":"Endocrine"},{"key":"1948_CR46","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/EJE-11-0929","volume":"166","author":"D Malanga","year":"2012","unstructured":"Malanga D, De Gisi S, Riccardi M et al (2012) Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype. Eur J Endocrinol 166:551\u2013560. https:\/\/doi.org\/10.1530\/EJE-11-0929","journal-title":"Eur J Endocrinol"},{"key":"1948_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa160","volume":"105","author":"F Chasseloup","year":"2020","unstructured":"Chasseloup F, Pankratz N, Lane J et al (2020) Germline CDKN1B loss-of-function variants cause pediatric Cushing\u2019s disease with or without an MEN4 phenotype. J Clin Endocrinol Metab 105:1\u201323. https:\/\/doi.org\/10.1210\/clinem\/dgaa160","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/510985","volume":"2015","author":"MS Elston","year":"2015","unstructured":"Elston MS, Meyer-rochow GY, Dray M et al (2015) Early onset primary hyperparathyroidism associated with a novel germline mutation in CDKN1B. Case Rep Endocrinol 2015:1\u20134. https:\/\/doi.org\/10.1155\/2015\/510985","journal-title":"Case Rep Endocrinol"},{"key":"1948_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/ERC-11-0362","volume":"19","author":"MA Tichomirowa","year":"2012","unstructured":"Tichomirowa MA, Lee M, Barlier A et al (2012) Cyclin-dependent kinase inhibitor 1B(CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds. Endocr Relat Cancer 19:233\u2013241. https:\/\/doi.org\/10.1530\/ERC-11-0362","journal-title":"Endocr Relat Cancer"},{"key":"1948_CR50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1530\/EJE-21-0075","volume":"185","author":"IM de LaPiscina","year":"2021","unstructured":"de LaPiscina IM, Najera NP, Rica I et al (2021) Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas. Eur J Endocrinol 185:485\u2013496. https:\/\/doi.org\/10.1530\/EJE-21-0075","journal-title":"Eur J Endocrinol"},{"key":"1948_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.773143","volume":"13","author":"E Lavezzi","year":"2022","unstructured":"Lavezzi E, Brunetti A, Smiroldo V et al (2022) Case report: new CDKN1B mutation in multiple endocrine neoplasia type 4 and brief literature review on clinical management. Front Endocrinol 13:1\u20137. https:\/\/doi.org\/10.3389\/fendo.2022.773143","journal-title":"Front Endocrinol"},{"key":"1948_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ando.2020.04.002","volume":"81","author":"B Chevalier","year":"2020","unstructured":"Chevalier B, Odou MF, Demonchy J et al (2020) Multiple endocrine neoplasia type 4: novel CDNK1B variant and immune anomalies. Ann Endocrinol (Paris) 81:124\u2013125. https:\/\/doi.org\/10.1016\/j.ando.2020.04.002","journal-title":"Ann Endocrinol (Paris)"},{"key":"1948_CR53","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2019-00082","volume":"104","author":"A Frederiksen","year":"2019","unstructured":"Frederiksen A, Rossing M, Hermann P et al (2019) Clinical features of multiple endocrine neoplasia type 4: novel pathogenic variant and review of published cases. J Clin Endocrinol Metab 104:3637\u20133646. https:\/\/doi.org\/10.1210\/jc.2019-00082","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10689-019-00152-6","volume":"19","author":"P Brock","year":"2020","unstructured":"Brock P, Bustamante Alvarez J, Mortazavi A et al (2020) Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report. Fam Cancer 19:189\u2013192. https:\/\/doi.org\/10.1007\/s10689-019-00152-6","journal-title":"Fam Cancer"},{"key":"1948_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/gim.2014.89","volume":"17","author":"C Esteban-Jurado","year":"2015","unstructured":"Esteban-Jurado C, Vila-Casades\u00fas M, Garre P et al (2015) Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer. Genet Med 17:131\u2013142. https:\/\/doi.org\/10.1038\/gim.2014.89","journal-title":"Genet Med"},{"key":"1948_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajhg.2018.04.013","volume":"103","author":"J Whitworth","year":"2018","unstructured":"Whitworth J, Smith PS, Martin JE et al (2018) Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes. Am J Hum Genet 103:3\u201318. https:\/\/doi.org\/10.1016\/j.ajhg.2018.04.013","journal-title":"Am J Hum Genet"},{"key":"1948_CR57","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","volume":"19","author":"SM Waszak","year":"2018","unstructured":"Waszak SM, Northcott PA, Buchhalter I et al (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19:785\u2013798. https:\/\/doi.org\/10.1016\/S1470-2045(18)30242-0","journal-title":"Lancet Oncol"},{"key":"1948_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jc.2012-1230","volume":"24","author":"SK Agarwal","year":"2018","unstructured":"Agarwal SK, Kester MB, Debelenko LV et al (2018) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 24:1\u20134. https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"1948_CR59","first-page":"83","volume":"118","author":"K Inoue","year":"2017","unstructured":"Inoue K, Fry EA (2017) Haploinsufficient tumor suppressor genes. Adv Med Biol 118:83\u2013122","journal-title":"Adv Med Biol"},{"key":"1948_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mce.2013.09.005","volume":"386","author":"J Costa-Guda","year":"2014","unstructured":"Costa-Guda J, Arnold A (2014) Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors. Mol Cell Endocrinol 386:46\u201354","journal-title":"Mol Cell Endocrinol"},{"key":"1948_CR61","first-page":"523","volume":"47","author":"M El Naofal","year":"2017","unstructured":"El Naofal M, Kim A, Yon HY et al (2017) Role of CDKN2C fluorescence in situ hybridization in the management of medullary thyroid carcinoma. Ann Clin Lab Sci 47:523\u2013528","journal-title":"Ann Clin Lab Sci"},{"key":"1948_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.beem.2010.01.001","volume":"24","author":"M Georgitsi","year":"2010","unstructured":"Georgitsi M (2010) MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27Kip1 and p18INK4C) mutations. Best Pract Res Clin Endocrinol Metab 24:425\u2013437","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1948_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/gcc.20621","volume":"48","author":"M Kirsch","year":"2009","unstructured":"Kirsch M, M\u00f6rz M, Pinzer T et al (2009) Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas. Genes Chromosomes Cancer 48:143\u2013154. https:\/\/doi.org\/10.1002\/gcc.20621","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01948-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01948-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01948-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T09:26:18Z","timestamp":1679045178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01948-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,5]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1948"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01948-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,5]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest that could prejudice the impartiality of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol for the study was approved by the institutional Ethics Committee of Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All procedures performed were in accordance with the ethical standards of the institution and with the 1964 Helsinki Declaration and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Written informed consent was obtained from all patients.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}